What is Sihuan Pharmaceutical Holdings Group OCF Margin %?
Sihuan Pharmaceutical Holdings GroupSHPHF 52 OCF Margin % is 4.87% as of Dec. 2025, which is 73% below its 10-year median of 18.22. GuruFocus rates SHPHF with a GF Score™ of 52/100 and a GF Value™ of $0.17 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 959 Drug Manufacturers companies, Sihuan Pharmaceutical Holdings Group ranks worse than 74.24% on this metric.
SHPHF'
s OCF Margin % Range Over the Past 10 Years
Min: -0.9 Med: 18.22 Max: 69.84
Current: -0.84
During the past 13 years, the highest OCF Margin % of Sihuan Pharmaceutical Holdings Group was 69.84%. The lowest was -0.90%. And the median was 18.22%.
SHPHF's OCF Margin % is ranked worse than 74.24% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.95
vs SHPHF: -0.84
Sihuan Pharmaceutical Holdings Group OCF Margin % Related Terms
Sihuan Pharmaceutical Holdings Group OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group OCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Sihuan Pharmaceutical Holdings Group's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sihuan Pharmaceutical Holdings Group OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sihuan Pharmaceutical Holdings Group's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Sihuan Pharmaceutical Holdings Group's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sihuan Pharmaceutical Holdings Group (SHPHF) has a OCF Margin % of 4.87% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. This is 73% below median its historical median of 18.22. According to the industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #712 out of 959 companies in the Drug Manufacturers industry, placing it in the top 74.2%.
Is Sihuan Pharmaceutical Holdings Group's OCF Margin % too high?
Sihuan Pharmaceutical Holdings Group's current OCF Margin % of 4.87% is 73% below median its 10-year median of 18.22. The Drug Manufacturers industry median OCF Margin % is 9.95. Sihuan Pharmaceutical Holdings Group's value of 4.87% is 51.1% below this industry median. Based on the distribution chart, Sihuan Pharmaceutical Holdings Group ranks #712 out of 959 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Sihuan Pharmaceutical Holdings Group has a GF Score™ of 52/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sihuan Pharmaceutical Holdings Group's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sihuan Pharmaceutical Holdings Group ranks #712 out of 959 companies for OCF Margin %. This places Sihuan Pharmaceutical Holdings Group in the lower half of its industry. The industry median OCF Margin % is 9.95. Sihuan Pharmaceutical Holdings Group's value of 4.87% is 51.1% below this benchmark. While the company's 10-year median is 18.22 vs. the industry median of 9.95, Sihuan Pharmaceutical Holdings Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sihuan Pharmaceutical Holdings Group's current OCF Margin % of 4.87% is 51.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Sihuan Pharmaceutical Holdings Group and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sihuan Pharmaceutical Holdings Group's current OCF Margin % is 4.87%, which is 73% below median its own 10-year median of 18.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sihuan Pharmaceutical Holdings Group stock overvalued right now?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group (SHPHF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.17, compared to a current price of $0.13 — trading 23.7% below its estimated fair value. The current OCF Margin % is 4.87%, which is 73% below median its 10-year median of 18.22 and 51.1% below the Drug Manufacturers industry median of 9.95. Sihuan Pharmaceutical Holdings Group's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Sihuan Pharmaceutical Holdings Group (SHPHF), the current OCF Margin % is 4.87% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sihuan Pharmaceutical Holdings Group (SHPHF) Overvalued in 2026?
Based on GuruFocus' analysis, Sihuan Pharmaceutical Holdings Group stock appears to be undervalued.
The current stock price of $0.13 is trading 23.7% below its estimated GF Value™ of $0.17.
GuruFocus considers Sihuan Pharmaceutical Holdings Group to be Modestly Undervalued.
Key valuation signals for SHPHF:
OCF Margin %: 4.87% (73% below median its 10-year median of 18.22)
GF Value™: $0.17 vs. price of $0.13 (23.7% below fair value)
Industry Position: 51.1% below the Drug Manufacturers median (#712 of 959)
No single metric tells the full story. See the SHPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sihuan Pharmaceutical Holdings Group Business Description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment, including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segment; and the generic medicine segment, which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
52GF Score
Get the complete analysis for SHPHF
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHPHF has been successfully added to your 
